TitleAuthorPublication DatePublisherType
    Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers  Semir, Vranic; Stafford, Phillip; Palazzo, Juan; Skenderi, Faruk; Swensen, Jeffrey; ... more authors 2020ElsevierArticle
    Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.  Imamovic, Denira; Vranic, Semir2017AME Publishing CompanyArticle
    PD-L1 status in breast cancer: Current view and perspectives.  Vranic, Semir; Cyprian, Farhan S; Gatalica, Zoran; Palazzo, Juan2019ElsevierArticle
    Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer.  Cyprian, Farhan S; Akhtar, Saghir; Gatalica, Zoran; Vranic, Semir2019Association of Basic Medical Sciences of Federation of Bosnia and HerzegovinaArticle Review